Gap Junction Protein, alpha 8, 50kDa (GJA8) (Middle Region) Peptid
GJA8
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN977421
Kurzübersicht für Gap Junction Protein, alpha 8, 50kDa (GJA8) (Middle Region) Peptid (ABIN977421)
Target
GJA8
(Gap Junction Protein, alpha 8, 50kDa (GJA8))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-GJA8 antibody (Catalog #: ARP36612_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- GJA8 (Gap Junction Protein, alpha 8, 50kDa (GJA8))
-
Hintergrund
-
One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. Defects in GJA8 are the cause of zonular pulverulent cataract type 1 (CZP1).
Alias Symbols: CAE, CAE1, CX50, CZP1, MP70
Protein Interaction Partner: MIP,TJP1,TJP1
Protein Size: 433 -
Molekulargewicht
- 48 kDa
-
Gen-ID
- 2703
-
NCBI Accession
- NM_005267, NP_005258
-
UniProt
- P48165
Target
-
Sie sind hier:
